Johnson & Johnson recently announced that the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended its single-shot COVID-19 vaccine under the recent FDA emergency use...
GSK recently announced results from a Phase 2 proof-of-concept trial evaluating its investigational monoclonal antibody treatment, otilimab.
The OSCAR study evaluated the efficacy and safety of...
FDA recently issued three guidance documents for COVID-19 vaccine developers and other medical product creators covering to address the current and potential future emergence of variants of...
FDA recently approved Bristol Meyer Squibb’s CAR-T cell therapy Breyanzi for the treatment of certain types of large B-cell lymphoma in patients who have not responded to previous treatment...
Roche recently announced that it received the CE mark for its new self-administered COVID-19 antigen test, which will be available in countries accepting the CE mark by the middle of this...
The Feinstein Institutes for Medical Research, part of Northwell Health, and Cold Spring Harbor Laboratory (CSHL) recently launched a fully virtual clinical trial to evaluate the safety and efficacy of...
AstraZeneca recently announced that its COVID-19 vaccine is safe and effective at preventing coronavirus in Phase 3 clinical trials from the UK, Brazil, and South Africa.
The first dose of...
Eli Lilly and Company recently announced that its COVID-19 neutralizing antibodies reduced coronavirus-related hospitalizations and deaths in high-risk patients by 70 percent in a Phase 3...
President Joe Biden recently signed an executive order to accelerate the development of novel COVID-19 therapies and improve access to care for all Americans.
First, Biden called on the HHS and...
Moderna recently announced that clinical trial researchers have dosed the first in the Phase 1/2 study of its mRNA COVID-19 vaccine, mRNA-1273, in Japan, led by Takeda Pharmaceuticals.
The...
Thermo Fisher Scientific recently announced that it entered into a $450 million definitive agreement to acquire San Diego-based Mesa Biotech, Inc. and boost the availability of reliable molecular...
Merck recently announced that it is discontinuing development of its COVID-19 vaccine candidates, V590 and V591, and will focus its research strategy on advancing its two other candidates, MK-4482 and...
Pfizer and BioNTech recently announced that its COVID-19 vaccine, BNT162b2, elicited antibodies that neutralize the SARS-CoV-2 UK strain, known as B.1.1.7 lineage.
The in-vitro study...
HHS recently announced that it will provide more than $22 billion in funding to states, localities, and territories to support COVID-19 testing and vaccination.
Over $19 billion of the funding,...
California Governor Gavin Newsom recently launched a campaign for safe, fair, and equitable distribution of a COVID-19 vaccine in all 58 counties of the state.
The “Vaccinate All 58”...
AstraZeneca recently announced that its cancer drug, Calquence elicited positive responses in a Phase 2 clinical trial of mantle cell lymphoma patients.
The Phase 2 trial, ACE-LY-004, uncovered...
Moderna recently announced that the first adolescent patients have been dosed in the Phase 2/3 study of its mRNA-based COVID-19 vaccine, mRNA-1273.
The randomized, controlled Phase 2/3 study will...
Bayer recently announced the launch of a cell and gene therapy platform (C>) within its pharmaceutical division.
The platform will further consolidate its emerging leadership in the cell and...
The implementation of a COVID-19 vaccination program will contribute more to the success a vaccine than drug efficacy, according to a recent Health Affairs study.
The study’s findings could...
Eli Lilly & Company and Precision BioSciences recently announced a collaboration to research and develop potential in vivo gene therapies for genetic disorders.
The collaboration and exclusive...
